Koji Nagai

2.9k citations
97 papers · 2.1k indexed · h-index 30
Topics
Microbial Natural Products and Biosynthesis (31 papers)Rheumatoid Arthritis Research and Therapies (12 papers)Fungal Biology and Applications (8 papers)

In The Last Decade

Koji Nagai

95 papers receiving 2.0k citations

Peers

Koji Nagai
Comparison fields: 5 of 125
  • Molecular Biology 915
  • Pharmacology 596
  • Organic Chemistry 587
  • Biotechnology 331
  • Rheumatology 284
Replace Glynn Faircloth with:
Glynn Faircloth Spain
Laurent Debüssche France
M. Tien Kuo United States
Junji Magae Japan
Tsutomu Oikawa Japan
Amy Roshak United States
Hiroyuki Kuroda Japan
Dennis S. France United States
Yuping Qiu China
Michiko Muramatsu Japan
Koji Nagai relative to Glynn Faircloth Spain Glynn Faircloth's profile →
Citations per field
00.5×3.7×
Glynn Faircloth · 1×
Citations per year

Countries citing papers authored by Koji Nagai

Since Specialization
Citations

This map shows the geographic impact of Koji Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Nagai more than expected).

Fields of papers citing papers by Koji Nagai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Nagai. The network helps show where Koji Nagai may publish in the future.

Co-authorship network of co-authors of Koji Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Nagai. A scholar is included among the top collaborators of Koji Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Nagai. Koji Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 14
3 6
4 39
5 21
6 7
7 62
8 20
9
Streptomyces olivoviridisの形質転換細胞における新しいアポトーシス誘導剤,チオビリダミド
1
10 58
11 31
12 10
13 24
14 10
15 34
16 21
17 4
18 29
19 51
20 32

About Koji Nagai

Koji Nagai is a scholar working on Pharmacology, Biotechnology and Microbiology, having authored 97 papers that have together received 2.1k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (31 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Fungal Biology and Applications (8 papers). The work is most often cited by research in Biotechnology (331 citations), Pharmacology (596 citations) and Organic Chemistry (587 citations). Koji Nagai has collaborated with scholars based in Japan, United Kingdom and Netherlands. Frequent co-authors include Kenichi Suzuki, Kazuo Shin‐ya, Yoichi Hayakawa, Kenichi Suzuki, Masatoshi Taniguchi, Tohru Takeuchi, Ken‐ichi Suzumura, Takuya Kotani, Kazuo Furihata and Nobuhiro Fusetani. Their work appears in journals such as Angewandte Chemie International Edition, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026